<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T19:30:26Z</responseDate>
  <request identifier="oai:figshare.com:article/33986797" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33986797</identifier>
        <datestamp>2026-10-09T18:04:19Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Matrix-Resolved Profiling of the Prenatal Chemical
Exposome Reveals Selective Placental Retention and Fetal Transfer</dc:title>
          <dc:creator>Montse Marquès (17350326)</dc:creator>
          <dc:creator>Ruben Gil-Solsona (11687132)</dc:creator>
          <dc:creator>Ana González-Ruiz (24797545)</dc:creator>
          <dc:creator>Esteban Restrepo-Montes (17350332)</dc:creator>
          <dc:creator>Ana Megía (25104745)</dc:creator>
          <dc:creator>Monica Ballesteros (25104748)</dc:creator>
          <dc:creator>José L. Domingo (1952986)</dc:creator>
          <dc:creator>Ana Navas-Acien (27358)</dc:creator>
          <dc:creator>Gary W. Miller (50264)</dc:creator>
          <dc:creator>Adrian Covaci (508263)</dc:creator>
          <dc:creator>Pablo Gago-Ferrero (1506517)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>resolution mass spectrometry</dc:subject>
          <dc:subject>primary physicochemical determinant</dc:subject>
          <dc:subject>prenatal chemical exposure</dc:subject>
          <dc:subject>increase disease vulnerability</dc:subject>
          <dc:subject>including organophosphate esters</dc:subject>
          <dc:subject>chemical landscape across</dc:subject>
          <dc:subject>based analysis across</dc:subject>
          <dc:subject>wide association studies</dc:subject>
          <dc:subject>umbilical cord serum</dc:subject>
          <dc:subject>profiled 659 chemicals</dc:subject>
          <dc:subject>personal care products</dc:subject>
          <dc:subject>including food additives</dc:subject>
          <dc:subject>multiple emerging contaminants</dc:subject>
          <dc:subject>matrix exposome profiling</dc:subject>
          <dc:subject>using wide</dc:subject>
          <dc:subject>transformation products</dc:subject>
          <dc:subject>resolved profiling</dc:subject>
          <dc:subject>maternal serum</dc:subject>
          <dc:subject>industrial chemicals</dc:subject>
          <dc:subject>contaminants </dc:subject>
          <dc:subject>transplacental transfer</dc:subject>
          <dc:subject>transplacental passage</dc:subject>
          <dc:subject>specific distribution</dc:subject>
          <dc:subject>spain ),</dc:subject>
          <dc:subject>selected biomarkers</dc:subject>
          <dc:subject>scalable framework</dc:subject>
          <dc:subject>related compounds</dc:subject>
          <dc:subject>related biomarkers</dc:subject>
          <dc:subject>pregnancy cohorts</dc:subject>
          <dc:subject>placental tissue</dc:subject>
          <dc:subject>placental retention</dc:subject>
          <dc:subject>passive diffusion</dc:subject>
          <dc:subject>maternal urine</dc:subject>
          <dc:subject>insulin cohort</dc:subject>
          <dc:subject>infant dyads</dc:subject>
          <dc:subject>human development</dc:subject>
          <dc:subject>flame retardants</dc:subject>
          <dc:subject>first time</dc:subject>
          <dc:subject>findings highlight</dc:subject>
          <dc:subject>fetal transfer</dc:subject>
          <dc:subject>23 mother</dc:subject>
          <dc:description>Chemical exposure during human development, especially in utero,
can disrupt many biological processes and increase disease vulnerability.
Assessing the chemical landscape across the maternal–fetal
interface is challenging. Here we address this challenge by conducting
an exposome-based analysis across a suite of integrated maternal–fetal
biological compartments: maternal urine, maternal serum, placental
tissue, and umbilical cord serum. Using wide-scope liquid chromatography–high-resolution
mass spectrometry (LC-HRMS) in 23 mother-infant dyads from the INSULIN
cohort (Spain), we profiled 659 chemicals and transformation products,
enabling a comprehensive characterization of prenatal chemical exposure
and its compartment-specific distribution. We identified 76 unique
compounds, including food additives, personal care products, pharmaceuticals,
plasticizers, pesticides, flame retardants, industrial chemicals,
and tobacco-related biomarkers. Matrix-resolved profiling revealed
distinct compartmentalization patterns, with lipophilicity (logP)
emerging as the primary physicochemical determinant of placental retention
and transplacental transfer, while active transport mechanisms governed
the fetal transfer of selected compounds despite properties inconsistent
with passive diffusion. We report, for the first time, the transplacental
passage of multiple emerging contaminants, including organophosphate
esters, food-related compounds and personal care product ingredients.
In contrast, several other contaminantssuch as selected biomarkers
of plastics, smoke, and personal care productsshowed no evidence
of transplacental transfer. These findings highlight the value of
comprehensive, multi-matrix exposome profiling for assessing prenatal
chemical exposures and provide a scalable framework for exposome-wide
association studies in pregnancy cohorts and beyond.</dc:description>
          <dc:date>2026-10-06T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/acs.est.6c02272.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Matrix-Resolved_Profiling_of_the_Prenatal_Chemical_Exposome_Reveals_Selective_Placental_Retention_and_Fetal_Transfer/33986797</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
